The effect of oriental medicine music therapy on "hwa-byung" patients

The effect of Oriental medicine Music THerapy on "hwa-byung" patients: a randomized double-blind parallel-group trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11939282

Enrollment

Registered

2011-09-19

Start date

2011-04-06

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hwa-byung (anger syndrome) Mental and Behavioural Disorders Hwa-byung (anger syndrome)

Interventions

1. Oriental medicine music therapy (active music therapy) and placebo music therapy 2. Treatment: 2 sessions/week 3. Duration: 4 weeks 4. Followed up for 4 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or female over 20 2. Diagnosed as hwa-byung using hwa-byung Structured Clinical Interview (SCID) for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 3. Written informed consent form taken 4. Has no problems with communication (reading, writing, listening, speaking, etc.)

Exclusion criteria

Exclusion criteria: 1. In need of regular medication or psychotherapy 2. Has a severe neuro- or psychiatric disorder 3. Has a history of major neuro-psychiatric disorder (autism, learning disorder, mental retardation etc.) 3. Had a change in medication of anti-depressant or barbiturate in the past one month 4. Seriously irritable patient 5. Participated in any other clinical trial in the past 1 month from the screening day 6. Had a regular mind-body relaxation training in the past 1 year, music therapy, qigong, yoga, and meditation 7. Cannot understand written informed consent form or follow this study 8. Mental retardation and mental or emotional problems.

Design outcomes

Primary

Measure	Time frame
State-Trait Anxiety Inventory (STAI), measured at Visit 2 (Day 1, their first treatment session), Visit 9 (Day 25, their last treatment session), and Visit 10 (Day 53, the follow-up)	—

Secondary

Measure	Time frame
1. Hwa-byung scale 2. The Center for Epidemiologic Studies Depression Scale (CES-D) 3. State-Trait Anger Expression Inventory (STAXI) 4. Hwa-byung primary symptoms Visual Analogue Scale (VAS) 5. World Health Organization Quality of Life (WHOQOL-BREF) 6. Salivary cortisol Measured at Visit 2 (Day 1, their first treatment session), Visit 9 (Day 25, their last treatment session), and Visit 10 (Day 53, the follow-up).	—

Measure

Time frame

1. Hwa-byung scale 2. The Center for Epidemiologic Studies Depression Scale (CES-D) 3. State-Trait Anger Expression Inventory (STAXI) 4. Hwa-byung primary symptoms Visual Analogue Scale (VAS) 5. World Health Organization Quality of Life (WHOQOL-BREF) 6. Salivary cortisol Measured at Visit 2 (Day 1, their first treatment session), Visit 9 (Day 25, their last treatment session), and Visit 10 (Day 53, the follow-up).

—

Countries

Korea, South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026